| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absence of protein 2C from clarified foot-and-mouth disease virus vaccines provides the basis for distinguishing convalescent from vaccinated animals
|
Lubroth, J.
|
|
1996
|
14 |
5 |
p. 419-427
9 p.
|
artikel
|
| 2 |
An investigation into the immunogenicity of a GnRH analogue in male rats: a comparison of the toxicity of various adjuvants used in conjunction with GnRH-glycys
|
Ferro, V.A.
|
|
1996
|
14 |
5 |
p. 451-457
7 p.
|
artikel
|
| 3 |
A simple, quantitative, reproducible avidin-biotin ELISA for the evaluation of group B Streptococcus type-specific antibodies in humans
|
Basham, Lisa E.
|
|
1996
|
14 |
5 |
p. 439-445
7 p.
|
artikel
|
| 4 |
Calendar
|
|
|
1996
|
14 |
5 |
p. 459-
1 p.
|
artikel
|
| 5 |
Comparative efficiency of simple lipopeptide constructs for in vivo induction of virus-specific CTL
|
Deprez, Benoît
|
|
1996
|
14 |
5 |
p. 375-382
8 p.
|
artikel
|
| 6 |
Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptides
|
Hioe, Catarina E.
|
|
1996
|
14 |
5 |
p. 412-418
7 p.
|
artikel
|
| 7 |
Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system
|
Fries, L.F.
|
|
1996
|
14 |
5 |
p. 428-434
7 p.
|
artikel
|
| 8 |
Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization
|
Klugman, Keith P.
|
|
1996
|
14 |
5 |
p. 435-438
4 p.
|
artikel
|
| 9 |
Induction of pneumococcal polysaccharide-specific mucosal immune responses by oral immunization
|
VanCott, John L.
|
|
1996
|
14 |
5 |
p. 392-398
7 p.
|
artikel
|
| 10 |
Legionella pneumophila DNA coding for major outer membrane protein; serogroup-1 Philadelphia strain 29 kDa recombinant major outer membrane protein production; DNA sequence; application in diagnosis and recombinant vaccine
|
|
|
1996
|
14 |
5 |
p. 458-
1 p.
|
artikel
|
| 11 |
Molecular size characterization of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines
|
Plumb, J.E.
|
|
1996
|
14 |
5 |
p. 399-404
6 p.
|
artikel
|
| 12 |
Mutant pertussis holotoxin with minimal residual toxicity-site-directed mutagenesis and protein engineering for recombinant vaccine production in Bordetella pertussis
|
|
|
1996
|
14 |
5 |
p. 458-
1 p.
|
artikel
|
| 13 |
Nickel binding protein isolated from Helicobacter pylori; useful in diagnosis and treatment of H. pylori infection, eg. in gastric disorders, and for non-clinical nickel detoxification
|
|
|
1996
|
14 |
5 |
p. 458-
1 p.
|
artikel
|
| 14 |
Polypeptides for vaccination against Neisseria meningitidis group-B; transferrin receptor recombinant vaccine and therapeutic monoclonal antibody production; protein engineering for partial deletion of at least one domain
|
|
|
1996
|
14 |
5 |
p. 458-
1 p.
|
artikel
|
| 15 |
Safety and immunogenicity of a tetravalent group B streptococcal polysaccharide vaccine in healthy adults
|
Kotloff, Karen L.
|
|
1996
|
14 |
5 |
p. 446-450
5 p.
|
artikel
|
| 16 |
Suppression of virus burden by immunization with feline immunodeficiency virus Env protein
|
Hosie, Margaret J.
|
|
1996
|
14 |
5 |
p. 405-411
7 p.
|
artikel
|
| 17 |
The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies
|
Ibsen, Per H.
|
|
1996
|
14 |
5 |
p. 359-368
10 p.
|
artikel
|
| 18 |
The N-terminal 303 amino acids of the human cytomegalovirus envelope glycoprotein B (UL55) and the exon 4 region of the major immediate early protein 1 (UL123) induce a cytotoxic T-cell response
|
Berencsi, Klara
|
|
1996
|
14 |
5 |
p. 369-374
6 p.
|
artikel
|
| 19 |
Vaccine and therapeutic composition containing Helicobacter pylori HAP protein; recombinant vaccine production
|
|
|
1996
|
14 |
5 |
p. 458-
1 p.
|
artikel
|
| 20 |
What is an acceptable delay in rabies immune globulin administration when vaccine alone had been given previously?
|
Khawplod, Pakamatz
|
|
1996
|
14 |
5 |
p. 389-391
3 p.
|
artikel
|
| 21 |
Yeast expressing hepatitis B virus surface antigen determinants on its surface: implications for a possible oral vaccine
|
Schreuder, M.P.
|
|
1996
|
14 |
5 |
p. 383-388
6 p.
|
artikel
|
Tijdschrift beschrijving